Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality improvement
- PMID: 19643443
- PMCID: PMC4035352
- DOI: 10.1016/j.jpeds.2009.06.005
Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality improvement
Abstract
Objective: To describe the frequency of diagnostic testing for the 4 most common causes of pediatric acute liver failure (PALF) (drugs, metabolic disease, autoimmune process, and infections) in indeterminate PALF within the PALF Study Group Database.
Study design: PALF was defined by severe hepatic dysfunction within 8 weeks of onset of illness, with no known underlying chronic liver disease in patients from birth through 17 years of age.
Results: Of the 703 patients in the database, 329 (47%) had indeterminate PALF. In this group, a drug history was obtained in 325 (99%) urine toxicology screenings performed in 118 (36%) and acetaminophen level measured in 124 (38%) patients. No testing for common metabolic diseases was done in 179 (54%) patients. Anti-nuclear antibody, anti-smooth muscle antibody, and anti-liver kidney microsomal autoantibodies associated with autoimmunity were determined in 239 (73%), 233 (71%), and 208 (63%) patients, and no tests were obtained in 70 (21%). Testing was performed for hepatitis A virus, hepatitis B virus, and Epstein Barr virus in 80%, 86%, and 68%, respectively.
Conclusions: Current practice indicates that investigation for metabolic and autoimmune causes of PALF are infrequent in patients ultimately given a diagnosis of indeterminate acute liver failure. This offers an opportunity to improve diagnosis and potential treatment options in children with acute liver failure.
Conflict of interest statement
The authors declare no conflicts of interest.
Comment in
-
The continuing challenge of "indeterminate" acute liver failure in children.J Pediatr. 2009 Dec;155(6):769-70. doi: 10.1016/j.jpeds.2009.07.060. J Pediatr. 2009. PMID: 19914425 No abstract available.
-
Acute liver failure and pediatric ALF: strategic help for the pediatric hepatologist.J Pediatr. 2010 Feb;156(2):342. doi: 10.1016/j.jpeds.2009.09.024. J Pediatr. 2010. PMID: 20105654 No abstract available.
References
-
- Aydogdu S, Ozgenc F, Yurtsever S, Akman SA, Tokat Y, Yagci RV. Our experience with fulminant hepatic failure in Turkish children: etiology and outcome. J Trop Pediatr. 2003;49:367–70. - PubMed
-
- Liu E, MacKenzie T, Dobyns EL, Parikh CR, Karrer FM, Narkewicz MR, et al. Characterization of acute liver failure and development of a continuous risk of death staging system in children. J Hepatol. 2006;44:134–41. - PubMed
-
- Ee LC, Shepherd RW, Cleghorn GJ, Lewindon PJ, Fawcett J, Strong RW, et al. Acute liver failure in children: A regional experience. J Paediatr Child Health. 2003;39:107–10. - PubMed
-
- Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137:947–54. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical